Quality · Access · Hope
Countries

🇲🇹 Country Profile

Malta

Fast-growing pharmaceutical trade with Malta

🇲🇹 $285M
Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Jan–Dec). Eurostat records what Malta imports from India. DGCIS records what India exports to Malta. Category and product detail from DGCIS.
$285M
Scale
Malta's patients receive $285M in Indian pharmaceutical products annually — almost entirely finished medicines ready for dispensing.
95%
Medicine
Overwhelmingly finished medicines — drug formulations account for 95% of shipments.
5.2×
Trajectory
Rapid expansion: Malta's imports of Indian pharmaceutical products have grown 5.2× over the past decade, from $54.3M to $285M.
Context
Part of India's pharmaceutical supply network across Europe.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Malta — building trade and operational presence.
Export Trend Eurostat CY DGCIS India-reported
Beyond Finished Medicines DGCIS CY 2014–2025

Additional pharmaceutical categories from DGCIS — APIs, surgical, herbal, and more

Category Mix — FY 2025–26 DGCIS
Medicines $315M (95.2%) Medicine Ingredients $15.8M (4.8%) Surgical & Hospital Supplies $0.05M (0.0%) Traditional & Herbal $0.02M (0.0%)
Top Products — FY 2025–26 DGCIS
Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $15.0M in active pharmaceutical ingredients and bulk drugs to Malta in 2025 (India-reported, DGCIS).

Indian Pharma Investment in Malta Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Malta: $26.4M across 12 filings (2014-2026).